Mesothelioma
Mesothelioma
Advertisement
Cecilia BrownNon-Small Cell Lung Cancer | July 24, 2024
The initiative aims to increase biomarker testing rates in communities most impacted by lung cancer disparities.
Read More
Leah LawrenceASCO 2024: Focus on Lung Cancer | July 3, 2024
A pilot study evaluated neoadjuvant platinum, pemetrexed, and nivolumab followed by pleurectomy/decortication.
Katie KoskoASCO 2024: Focus on Lung Cancer | June 24, 2024
Nearly 80% of patients enrolled had epithelioid histology and 65% had an ECOG performance status of 1.
Cecilia BrownASCO 2024: Focus on Lung Cancer | June 5, 2024
Researchers evaluated the combination in an effort to “further enhance the immunogenicity" of the vaccine.
Kaitlyn KoskoMesothelioma | April 17, 2024
Occupational asbestos exposure leads to shorter survival in patients with malignant mesothelioma.
Kaitlyn KoskoMesothelioma | April 17, 2024
Guideline-concordant therapy remains underused in most mesothelioma patients.
Kaitlyn KoskoMesothelioma | March 22, 2024
A complete residential history should be reviewed following a mesothelioma diagnosis.
Kaitlyn KoskoMesothelioma | February 21, 2024
Radiation therapy with HT is safe and effective in patients with malignant pleural mesothelioma.
Rob DillardMesothelioma | February 5, 2024
Analyzing the exhaled breath of patients with mesothelioma shows tremendous potential as a screening tool.
Kaitlyn KoskoMesothelioma | December 26, 2023
A simple blood draw could help predict survival outcomes in patients with malignant pleural mesothelioma.
Mary GreccoWCLC 2023 | December 15, 2023
A study assessed the impact of immunotherapy on OS in patients with malignant pleural mesothelioma.
Mary GreccoWCLC 2023 | December 14, 2023
Adoptive cell therapy with autologous TILs was studied to determine its viability as a treatment option for mesothelioma.
Rob DillardMesothelioma | November 14, 2023
Asbestos exposure led to a higher incidence of asbestos-related lung cancers in naval personnel.
Rob DillardMesothelioma | November 3, 2023
BAP1 immunohistochemistry and p16 (CDKN2A) deletion contribute to providing a definitive diagnosis of mesothelioma.
Kaitlyn D’OnofrioMesothelioma | September 21, 2023
Men and women living with mesothelioma may share similar experiences but have different concerns that nurses and other ...
Kaitlyn D’OnofrioMesothelioma | September 21, 2023
A qualitative study took a closer look at the experiences of military veterans in the UK living with mesothelioma.
Kaitlyn D’OnofrioMesothelioma | September 21, 2023
The Food and Drug Administration (FDA) has approved NovoTTF-100L System (Novocure) in conjunction with pemetrexed plus ...
Kerri FitzgeraldMesothelioma | September 21, 2023
A phase I study presented at the American Association of Clinical Research Annual Meeting showed that chimeric antigen ...
Advertisement
Advertisement
Advertisement
Latest News

July 26, 2024